Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-14

Clinical Trial Update: Study of MIGRA-ZEN RELIEF PLUS In the Treatment of Chronic Migraine Headache [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating MIGRA-ZEN RELIEF PLUS for chronic migraine. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIGRA-ZEN RELIEF PLUS

Snippet

Sponsor: RZN Nutraceuticals, Inc. | Conditions: Chronic Migraine | Phase 2 | Status: UNKNOWN